Fast Five Quiz: Metastatic Melanoma

Adil Daud, MD


March 15, 2023

To screen for recurrence or metastatic disease in patients with stage IIB-IV melanoma, the National Comprehensive Cancer Network (NCCN) guidelines recommend a comprehensive history and physical every 3-12 months for 2 years, then every 6-12 months for another 3 years and annually thereafter as indicated. Surveillance imaging may also be considered every 3-12 months for 2 years as well at the discretion of the physician, per the same guidelines. Further, routine imaging to screen for asymptomatic recurrence or metastatic disease is not indicated after 3-5 years because most recurrences occur within the first 3 years.

Learn more about patient follow-up in metastatic melanoma.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.